You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Express Scripts
Harvard Business School
AstraZeneca
Boehringer Ingelheim

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

Bundy Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BUNDY, and what generic and branded alternatives to BUNDY drugs are available?

BUNDY has eight approved drugs.



Summary for Bundy
US Patents:0
Tradenames:7
Ingredients:7
NDAs:8

Drugs and US Patents for Bundy

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bundy RESERPINE reserpine TABLET;ORAL 009663-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Bundy BUTABARBITAL butabarbital sodium TABLET;ORAL 085550-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Bundy RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 009477-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Dow
Harvard Business School
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.